Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis

Arthritis and Rheumatism

Volumn 40, Issue 10, 1997, Pages 1788-1797

  Yin, Zhinan ^a   Braun, Jürgen ^a   Neure, Lucia ^a   Peihua, W U ^b   Liu, Lanzhen ^b   Eggens, Ulrich ^a   Sieper, Joachim ^a,c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MALE; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REGULATORY MECHANISM; SALMONELLA ENTERITIDIS; SCHOOL CHILD; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE ACTIVATION; YERSINIA ENTEROCOLITICA;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; ARTHRITIS, REACTIVE; BACTERIAL INFECTIONS; CELL DIVISION; CELLS, CULTURED; CHILD; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; JOINTS; MALE; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0030804644     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401010     Document Type: Article

References (53)

1. Kingsley G, Panayi G: Antigenic responses in reactive arthritis. Rheum Dis Clin North Am 18:49-66, 1992
2. Keat A, Thomas B, Dixey J, Osborn M, Sonnex C, Taylor Robinson D: Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1:72-74, 1987
3. Granfors K, Jalkanen S, von Essen R, Lahesmaa Rantala R, Isomaki O, Pekkola Heino K, Merilahti Palo R, Saario R, Isomaki H, Toivanen A: Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 320:216-221, 1989
4. Granfors K, Jalkanen S, Lindberg AA, Maki Ikola O, von Essen R, Lahesmaa Rantala R, Isomaki H, Saario R, Arnold WJ, Toivanen A: Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 335:685-688, 1990
5. Taylor Robinson D, Gilroy CB, Thomas BJ, Keat AC: Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 340:81-82, 1992
6. Bas S, Griffais R, Kvien TK, Glennås A, Melby K, Vischer TL: Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 38:1005-1013, 1995
7. Sieper J, Braun J: Pathogenesis ot spondylarthropathies: persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 38: 1547-1554, 1995
8. Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N: Immunology of reactive arthritides. Annu Rev Immunol 13:229-250, 1995
9. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
10. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10:385-409, 1992
11. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-251, 1994
12. Trinchieri G: Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14:335-338, 1993
13. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451, 1991
14. Pirmez C, Yamamura M, Uyemura K, Paes Oliveira M, Conceicao Suva F, Modlin RL: Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91:1390-1395, 1993
15. Sieling PA, Wang X-H, Gately MK, Oliveros JL, McHugh T, Barnes PF, Wolf SF, Golkar L, Yamamura M, Yogi Y, Uyemura K, Rea TH, Modlin RL: IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 153:3639-3647, 1994
16. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J: Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 62:2590-2599, 1994
17. Autenrieth IB, Heesemann J: In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol (Berl) 181:333-338, 1992
18. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA: Inhibition of Chlamvdia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 63:2801-2803, 1995
19. Beatty WL, Byrne GI, Morrison RP: Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A 90:3998-4002, 1993
20. Kingsley G, Sieper J: Third international workshop on reactive arthritis: an overview. Ann Rheum Dis 55:564-570, 1996
21. Braun J, Tuszewski M, Eggens U, Mertz A, Schauer-Petrowskaja C, Döring E, Latitko S, Distler A, Sieper J, Ehlers S: Use of a nested PCR strategy simultaneously targeting DNA sequence of multiple bacterial species in inflammatory joint diseases. J Rheumatol 24:1092-1100, 1997
22. Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S, Sorensen H, Distler A, Kingsley G: Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 19:1236-1242, 1992
23. Braun J, Doring E, Wu P, Heesemann J, Treharne J, Eggens U, Sieper J: Synovial cellular immune response to bacterial pathogens in patients with chronic juvenile arthritis. Z Rheumatol 52:201-209, 1993
24. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chzzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interlcukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398, 1992
25. Melby PC, Darnell BJ, Tryon VV: Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods 159:235-244, 1993
26. Yin Z, Braun J, Neure L, Wu P, Eggens U, Krause A, Kamradt T, Sieper J: T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 40:69-79, 1997
27. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J: Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499-505, 1995
28. D'Andrea A, Aste Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048, 1993
29. Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 91:8562-8566, 1994
30. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991
31. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
32. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, Warrier RR, Pham N, Fogelman AM, Modlin RL: Cross-antigen roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97:2130-2138, 1996
33. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276, 1995
34. Lamont AG, Adorini L: IL-12: a key cytokine in immune regulation. Immunol Today 17:214-217, 1996
35. Bohn E, Autenrieth IB: IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol 156:1458-1468, 1996
36. Sornasse T, Larenas PV, Davis KA, de Vries JE, Yessel H: Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 184:473-483, 1996
37. Schlaak J, Hermann E, Ringhoffer M, Probst P, Gallati H, Meyer zum Buschenfelde KH, Fleischer B: Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur J Immunol 22:2771-2776, 1992
38. Simon AK, Seipelt E, Wu P, Wenzel B, Braun J, Sieper J: Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset. Clin Exp Immunol 94:122-126, 1993
39. Demeure CE, Wu CY, Shu U, Schneider PV, Heusser C, Yssel H, Delespesse G: In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol 152:4775-4782, 1994
40. Swain SL, Weinberg AD, English M, Huston G: IL-4 directs the development of Th2-like helper effectors. J Immunol 145:3796-3806, 1990
41. Del Prete G, De Carli M, D'Elios MM, Daniel KC, Almerigogna F, Alderson M, Smith CA, Thomas E, Romagnani S: CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 182:1655-1661, 1995
42. Burstein HJ, Abbas AK: In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med 177: 457-463, 1993
43. Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell D, Veromaa T, Waisman A, Gaur A, Conlon P, Ling N, Fairchild PJ, Wraith DC, O'Garra A, Fathman CG, Steinman L: Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343-346, 1996
44. Steinman L: A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci U S A 93:2253-2256, 1996
45. Kemp M, Theander TG, Kharazmi A: The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today 17:13-16, 1996
46. Keane Myers A, Maliszewski CR, Finlelman FD, Nickell SP: Recombinant IL-4 treatment augments resistance to borrelia burgdorferi infection in both normal susceptible and antibody-deficient susceptible mice. J Immunol 156:2488-2494, 1996
47. Bessis N, Fradelizi D, Fournier C, Bossier MC: Treatment of inflammation with anti-inflammatory cytokines: example in models of autoimmune diseases. C R Seances Soc Biol Fil 189:579-590, 1995
48. Mocci S, Coffman RL: Induction of a Th2 population from a polarized leishmania-specific Th1 population by in vitro culture with IL-4. J Immunol 154:3779-3787, 1995
49. Yang X, HayGlass KT, Brunham RC: Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 156:4338-4344, 1996
50. Holland MJ, Bailey RL, Conway DJ, Culley F, Miranpuri G, Byrne GI, Whittle HC, Mabey DCW: T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC): responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 105:429-435, 1996
51. Keane Myers A, Nickell SP: Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155:2020-2028, 1995
52. Nabors GS, Afonso LC, Farrell JP, Scott P: Switch from a type 2 to a type 1 T helper cell response and cure of established leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proc Natl Acad Sci U S A 92:3142-3146, 1995
53. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF: Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med 182:1067-1077, 1995